April 2012
`
`PHAR 406 Principles of Drug Action and Therapeutics VI: Chemistry of Antivirals, Fall 1999-
`2007 (lecturer)
`PMMP 323 Bioanalytical Chemistry, Fall 1994-1995, 1997 (lecturer), 1996 (coordinator)
`PMMP 623 Bioanalytical Chemistry, Spring 1995-2000 (coordinator)
`PMPG 480 Methods of Evaluating Biologically Active Natural Product Drugs, Spring 1998-
`2006; Fall 2009 (lecturer)
`PMPG 507 Drug Discovery, Design and Development, Fall 2005-2011 (lecturer)
`PMPG 510 Research Techniques in Pharmacognosy, Fall 1997-2011 (lecturer)
`PMPG 515 Structure Elucidation of Natural Products, Spring 1998, 2000 (lecturer)
`PMPG 495 Introduction to Pharmaceutical Biotechnology, Spring 1999 (lecturer)
`PMPG 511 Advanced Pharmacognosy II, Spring 2006-2012 (lecturer)
`International Training Program in New Crops: Aromatic and Medicinal Plants – 2000. Taught
`laboratory practicum on, “Medicinal plant analysis using HPLC and LC-MS.” University of
`Illinois at Chicago and Purdue University. Chicago, IL. June 19-30, 2000.
`
`RESEARCH STUDENTS AND POST-DOCTORAL FELLOWS SUPERVISED
`Graduate Students
`1. LeRoy B. Martin, III, Ph.D. Chemistry, 1990
`"Mass Spectrometry of Organometallics and Several Platinated Oligonucleotides"
`Current position: Mass spectrometry applications scientist with Micromass, Division of Waters,
`Danvers, MA
`2. David R. Goodlett, Ph.D. Biochemistry, 1991
`"Studies on the Active Site of Juvenile Hormone Esterase"
`Current position: Professor of Medicinal Chemistry, University of Washington, College of
`Pharmacy, Seattle, WA
`3. Chien-Hua Huang, Ph.D. Chemistry, 1991
`"Synthesis of Poly-3,3,3-trifluoro-1-phenylpropyne and Poly-1-phenylpropyne and
`Characterization by Chromatography and Mass Spectrometry"
`Current position: Chemist in Taiwan
`4. Roderick G. Davis, M.S. Chemistry, 1991
`"Rates of Proteolysis of Bioactive Peptides Determined Using HPLC and Mass Spectrometry"
`Current position: Mass spectrometry specialist, Research Resources Center, University of
`Illinois at Chicago, Chicago, IL
`5. Catherine Ann Culver, Ph.D. Food Science, 1991
`“Application of Immobilized Digestive Enzyme Assay Fluidized-bed Reactors and
`Characterization of Their Digests.”
`Current position: Principal scientist, Pepsi-Cola Co., Valhalla, NY
`6. Yinhsien Tsou, Ph.D. Chemistry, 1993
`"Degradation of Xenobiotic Compounds by Immobilized Enzymes and Cells"
`Current position: Killed in automobile accident
`
`
`
`
`
`
`24
`
`
`
`0000056
`
`

`
`April 2012
`
`7. Kevin Blackburn, M.S. Chemistry, 1993
`"Degradation of Lysobactin by Digestive Proteases"
`Current position: Analytical chemist, Glaxo SmithKline Pharmaceuticals, Research Triangle
`Park, NC
`8. Dejan Nikolic, Ph.D. Medicinal Chemistry, 1999
`“Screening of Combinatorial Chemistry Libraries Using Pulsed Ultrafiltration-Mass
`Spectrometry” Current position: Mass spectrometry lab manager and Research Assistant
`Professor, UIC/NIH Center for Botanical Dietary Supplements Research, University of Illinois
`College of Pharmacy, Chicago, IL
`9. Lixin Shen, M.S. Medicinal Chemistry, 1999
`“Analysis of DNA Oxidation Products using Liquid Chromatography-Mass Spectrometry”
`Current position: Mass spectrometrist, Roche Pharmaceuticals, Nutley, NJ
`10. Yecheng Tan, Graduate Student, 1995-2000
`“Liquid Chromatography-Mass Spectrometry of Oligonucleotides”
`Current position: Mass spectrometrist at Decode, Lemont, IL
`11. Xiaoying Xu, Ph.D. Pharmacognosy, 2000
`“Antiproliferative Effect of Lycopene on Prostate Cancer Cells”
`Current position: Group Leader Analytical and PMPK, Novartis, Shanghai, China
`12. Yan Wang, Ph.D. Medicinal Chemistry, 2001
`“Prevention of Prostate Cancer by Lycopene”
`Current position: Director of Proteomics, College of Chemical and Life Sciences, University of
`Maryland, College Park, MD
`13. Chongwoo Yu, Ph.D. Chemistry, 2002
`“Investigation of Resveratrol Metabolism using Liquid Chromatography-Mass Spectrometry”
`Current position: Office of Clinical Pharmacology, U. S. Food and Drug Administration, Silver
`Spring, MD
`14. Yanan Yang, Ph.D. Medicinal Chemistry, 2003
`“Quantitative Determination of DNA Oxidation and DNA Methylation by Using LC-UV-MS-
`MS” Current position: Mass spectrometrist, Agilent Technologies, Palo Alto, CA
`15. Benjamin M. Johnson, Ph.D. Medicinal Chemistry, 2003
`“Mass Spectrometric Assays for Electrophilic Metabolites of Natural Product Mixtures”
`Current position: Senior scientist, Bristol Myers Squibb, Wallingford, CT
`16. Spiros Garbis, Ph.D. Pharmacognosy, 2003
`“Bioavailability Studies of Folate in Humans”
`Current position: Staff research scientist, Academy of Athens, Foundation for Biomedical
`Research, Athens, Greece
`17. Yongmei Li, Ph.D. Pharmacognosy, 2004
`“Caco-2 cell permeation studies and metabolism of botanical natural products”
`Current position: Senior Scientist in Drug Metabolism and Pharmacokinetics. Boehringer
`Ingelheim, Ridgeland, CT
`18. Natasa Pajkovic, Ph.D. Medicinal Chemistry, 2005
`“Prevention of Prostate Cancer by Lycopene”
`Current position: Senior Scientist in Drug Metabolism. Merck, West Point, PA
`
`
`
`
`
`
`25
`
`
`
`0000057
`
`

`
`April 2012
`
`19. Wenzhong Liang, Ph.D. Pharmacognosy, 2005
`“Pharmacokinetics and metabolism studies of active compounds in botanical dietary supplements
`for womens’ health”
`Current position: Senior Scientist at Pharmaceutical Product Development, Inc. Madison, WI
`20. Xun Cheng, Ph.D. Medicinal Chemistry, 2005
`“Ultrafiltration Mass Spectrometric Screening for Inhibitors of Macromolecular Aggregation”
`Current position: Senior Scientist at Affymax, Palo Alto, CA
`21. Yongkai Sun, Ph.D. Medicinal Chemistry, 2005
`“Characterization of estrogens using ultrafiltration mass spectrometry”
`Current position: Scientist at Celgene, Summit, NJ
`22. Xiaofeng Yang, Ph.D. Medicinal Chemistry, 2005
`“Studies of protein covalent modifications using mass spectrometry”
`Current position: Scientist I at Millennium Pharmaceuticals, Cambridge, MA
`23. Guowen Liu, Ph.D. Medicinal Chemistry, 2005
`“Screening for potential chemopreventive agents targeting human Keap1 and human RARγ
`using mass spectrometry”
`Current position: Scientist at Bristol Myers Squibb, New Brunswick, NJ
`24. Dongwei Zhu, Ph.D. Medicinal Chemistry, 2006
`“β-Carotene bioefficacy and prevention of lipid peroxidation by lycopene”
`Current position: Research Scientist at Xenobiotics Laboratory, Plainsboro, NJ
`25. Yan Pang, Ph.D. Medicinal Chemistry, 2006
`“In vitro studies of intestinal absorption, blood brain barrier permeability and metabolism of
`natural products using mass spectrometry”
`Current position: Senior Scientist in Drug Metabolism at Abbott Laboratories, Abbott Park, IL
`26. Aarti Sawant, Ph.D. Medicinal Chemistry, 2006
`“In vitro and in vitro identification and evaluation of electrophilic precursors in natural products”
`Current position: Senior Scientist at Pfizer, Groton, CT
`27. Yi Tao, Ph.D. Medicinal Chemistry, 2007
`“Characterization of cyclooxygenase-2 inhibitors from ginger dietary supplements and in vitro
`metabolism studies of gingerol-related compounds”
`Current position: Director of DMPK, GlaxoSmithKline Research and Development, Shanghai,
`China
`28. Yan Luo, Graduate Student, Ph.D. Medicinal Chemistry, 2008
`“Application of proteomics mass spectrometry to the Keap1/Nrf2 chemoprevention pathway”
`Current position: Mass spectrometrist, at Dow Chemical, Shanghai, China
`29. Long Yuan, Ph.D. Medicinal Chemistry, 2008
`“Identification and quantitative analysis of DNA damage products using LC-MS-MS”
`Current position: Senior Investigator at Bristol-Myers Squibb, New Brunswick, NJ.
`30. Jian Guo, Ph.D. Medicinal Chemistry, 2008
`“Metabolism of active compounds in botanical dietary supplements”
`Current position: Senior Investigator at Astrazeneca, Wilmington, DE.
`31. Dongting Liu, Ph.D. Medicinal Chemistry, 2008
`
`
`
`
`
`
`26
`
`
`
`0000058
`
`

`
`April 2012
`
`“Screening natural products for cancer chemopreventive agents based on binding to RXRα and
`alkylation of Keap1”
`Current position: Senior Scientist at Dow Chemical, Indianapolis, IN
`32. Ang Liu, Ph.D. Medicinal Chemistry, 2008
`“Mechanisms of prostate cancer prevention by lycopene”
`Current position: Principal Investigator, Matrix Bioanalytical Laboratories, New Haven, CT
`33. Hongmei Cao, Ph.D. Medicinal Chemistry, 2009
`“Role of cyclooxygenases in inflammation and chemoprevention”
`Current position: Senior Scientist at Shire Pharmaceuticals, Lexington, MA
`34. Jeffrey H. Dahl, Ph.D. Medicinal Chemistry, 2010
`“Antioxidant effects and metabolism of lycopene”
`Current position: Scientist at Shimadzu Instruments, Columbia, MD
`35. Jinghu Carl Li, Ph.D. Medicinal Chemistry, 2010
`“Studies of metabolism and disposition of natural products using mass spectrometry”
`Current position: Senior Research Scientist at AMRI, Albany, NY
`36. Chenqi Hu, Ph.D. Medicinal Chemistry, 2011
`“Analysis of Nrf2-Keap1 chemoprevention signaling using mass spectrometry”
`Current position: Scientist at Amgen, Cambridge, MA
`37. Zhiyuan Sun, M.S. Medicinal Chemistry, 2011
`“Mass Spectrometric studies of Keap1-Nrf2 binding interactions.”
`Current position: Staff Scientist in University of Pittsburgh Proteomics Center, Pittsburgh, PA
`38. Soyoun Ahn, Ph.D. Pharmacognosy, 2011
`“In vitro studies of intestinal absorption and blood-brain barrier penetration of pharmacologically
`active compounds using cell monlayer models combined with HPLC-mass spectrometry”
`Current position: Postdoctoral fellow at Oregon State University, Corvallis, OR
`39. Yang Song, Ph.D. Pharmacognosy, 2011 “ADMEt Evaluation of Anti-tuberculosis
`Compounds and New Methodologies Development.”
`Current position: Senior Scientis at Chemocentryx, San Francisco, CA
`40. Linlin Dong, Graduate Student, 2007-present
`“Carotenoid bioavailability and chemoprevention mechanisms”
`41. Rui Yu, Graduate Student, 2007-present
`“Prostaglandins and asthma”
`42. Ke Huang, Graduate Student, 2007-present
`“Metabolism of chemoprevention agents”
`43. Lian Chen, Graduate Student, 2008-present
`“Discovery of chemoprevention agents targeting RXRα”
`44. Yang Yuan, Graduate Student, 2008-present
`“Microfluidics LC-MS-MS analysis of DNA alkylation products in human tissue”
`45. Jerry White, Graduate Student, 2008-present
`“Determination of sites of binding of selective HDAC inhibitors”
`46. Kevin Krock, Graduate Student, 2008-present
`“Mass spectrometry-based discovery of β-amyloid aggregation inhibitors”
`
`
`
`
`
`
`27
`
`
`
`0000059
`
`

`
`April 2012
`
`47. Brian Wright, Graduate Student, 2008-present
`“Pharmacokinetics of cocoa antioxidants”
`48. Yongchao Li, Graduate Student, 2009-present
`“Mechanisms of lycopene uptake by prostate cells”
`49. Andrew Newsome, Graduate Student, 2009-present
`“Discovery of food pigments and chemoprevention agents from extremophiles”
`50. Caleb Nienow, Graduate Student, 2010-present
`“Mass spectrometry investigation of binding modes of selective HDAC inhibitors”
`
`Undergraduates and High School Students
`Michael G. Bartlett, B.A. 1990. North Carolina State University, Raleigh, NC.
`Senior undergraduate research project in chemistry."Degradation of Bioactive Peptides by
`Immobilized Proteases."
`Subsequent position: Ph.D. program, Dept. of Chemistry, Indiana University, Bloomington, IN.
`Current position: Professor of Medicinal Chemistry, College of Pharmacy, University of
`Georgia, Athens, GA.
`Jack Thornquest, B.A. 1992. North Carolina State University, Raleigh, NC. Senior
`undergraduate research project in chemistry. "Interaction of Phage mRNA with a Regulatory
`Protein." Subsequent position: Ph.D. program, Dept of Chemistry, Univ. of North Carolina at
`Chapel Hill.
`Jacob Lai, B.S. 2000. Northwestern University, Evanston, IL. Summer research 1996-1999.
`Subsequent position, Ph.D. program, Dept. of Chemistry, Stanford University, Palo Alto, CA.
`Current position, Senior Chemist, Alza (Johnson & Johnson), Mountain View, CA.
`Jacob Lai and Donald Park. 1994-1995. Illinois Mathematics and Science Academy, Aurora, IL.
`High school science project supervisor/mentor. “C18 reversed phase high-performance liquid
`chromatography and mass spectrometry of oligonucleotides.”
`Priscilla A. Bernikowicz. 1995-1996. Lincoln Park High School, Chicago, IL. High school
`science project supervisor/mentor. “Nicotine analysis and ETS exposure.” Named Semifinalist in
`the national Westinghouse 55th Annual Science Talent Search. Attended Northwestern
`Univeristy.
`Helen Feinstein, Jennifer Mack and Donald Park. 1995-1996. Illinois Mathematics and Science
`Academy, Aurora, IL. High school science project supervisor/mentor. “Affinity LC-MS of
`antisense oligonucleotides.”
`Bradley Jellerichs and Angela Janis. 1996-1997. Illinois Mathematics and Science Academy,
`Aurora, IL. High school science project supervisor/mentor. “Synthesis of oxidized
`deoxynucleosides.”
`Adam Rojan. 1997-1998. Illinois Mathematics and Science Academy, Aurora, IL. High school
`science project supervisor/mentor. “Pulsed ultrafiltration affinity constant measurements.”
`Marissa Fierz. 1998-1999. Illinois Mathematics and Science Academy, Aurora, IL. High school
`science project supervisor/mentor. “Degradation products of lycopene and their linkage to
`prostate cancer.”
`
`
`
`
`
`
`28
`
`
`
`0000060
`
`

`
`April 2012
`
`Eric Bunnelle and Stephen Trevick, 2000-2001. Illinois Mathematics and Science Academy,
`Aurora, IL. High school science project supervisor/mentor. “Pulsed ultrafiltration measurement
`of receptor-ligand interactions.” Eric Bunnelle attended the University of Illinois at Champaign-
`Urbana as a chemical engineering major.
`Kevin Yang and Sri P. Vagvala, 2001-2002. Illinois Mathematics and Science Academy, Aurora,
`IL. High school science project supervisor/mentor. “Chamber miniaturization to shorten assay
`time and minimize ligand and receptor consumption during pulsed ultrafiltration.”
`Alex Viana, B.S. 2007. University of Wisconsin, Madison, WI. Summer research 2001-2003.
`“Evaluation of the safety and efficacy of botanical dietary supplements as alternatives to
`hormone replacement therapy.” Current position: M.S. program in astronomy, the Johns
`Hopkins University, Baltimore, MD.
`Brent Terry-Penak, 2009. St. Ignatius College Prep, Chicago, IL. High school summer research
`internship. “Ion mobility mass spectrometry of lycopene.”
`Summer 2010 and 2011. California Institute of Technology, Pasdena, CA. “Ion mobility mass
`spectrometry of lycopene.”
`
`Postdoctoral Fellows
`1. Chien-Hua Huang, Post-doctoral fellow 1991-1993
`"Liquid Chromatography-Mass Spectrometry of Serum Carotenoids"
`Current position: Chemist in Taiwan
`2. Chao-Ran Huang, Post-doctoral fellow 1994-1996
`"Liquid Chromatography-Mass Spectrometry of Carotenoids"
`Current position: Senior scientist at Biogen Idec, Cambridge, MA
`3. Henry Xiong, Postdoctoral Fellow, 1997-1998
`“Prevention of DNA Oxidation by Carotenoids”
`Current position: Mass spectrometry applications specialist at Micromass, Waters Inc., Danvers,
`MA
`4. Samuel B. Wainhaus, Postdoctoral Fellow, 1998-1999
`“LC-MS-MS Quantitation of DNA Oxidation Products”
`Current position: Senior scientist, Schering-Plough Pharmaceuticals, Kennilworth, NJ
`5. Dejan Nikolic, Post-doctoral fellow, 1999-2001
`Current Position: Research assistant professor, mass spectrometry laboratory manager, UIC/NIH
`Center for Botanical Dietary Supplements Research, University of Illinois at Chicago
`6. Yousheng Hua, Postdoctoral Fellow, 1999-2000
`“LC-MS-MS Quantitation of DNA Oxidation Products”
`Current position: Senior Scientist at Baxter, Technology Resources/Physics & Chemistry
`Department. Round Lake, IL.
`7. Young-Guen Shin, Postdoctoral Fellow, 1999-2001
`“Natural Inhibitors of Carcinogenesis, LC-MS-MS Applications”
`Current position: Senior scientist, Genentech, South San Francisco, CA
`8. Chuck Gu, Postdoctoral Fellow,1999-2001
`“NCI LC-MS-MS Core for Cancer Research”
`Current position: Senior Scientist at Astrazeneca, Wilmington, DE
`
`
`
`
`
`
`29
`
`
`
`0000061
`
`

`
`April 2012
`
`9. Liqiong Fang, Postdoctoral Fellow, 1999-2002
`“Prevention of Prostate Cancer by Lycopene”
`Current Position: Senior Scientist at Baxter Healthcare, Round Lake, IL
`10. Wenkui Li, Postdoctoral Fellow, 2001-2003
`“Standardization of Botanical Dietary Supplements”
`Current Position: Senior Scientist at Novartis, East Hanover, NJ
`11. Huaping Wu, Postdoctoral Fellow, 2001-2004
`“Mass Spectrometry-based Proteomics”
`Current position: Research scientist, Illinois Institute of Technology, Chicago IL
`12. Sool Yeon Cho, Postdoctoral Fellow, 2002-2004
`“Lycopene Degradation Products and Cancer Chemoprevention”
`Current position: Postdoctoral Fellow, New York University School of Medicine, New York,
`NY
`13. Zorica Vujic, Postdoctoral Fellow, 2003-2004
`“Mechanism of Prostate Cancer Prevention by Lycopene”
`Current Position: Lecturer in Medicinal Chemistry, School of Pharmacy, Belgrade University,
`Belgrade, Serbia
`14. Christopher Pennington, Postdoctoral Fellow, 2006-2007
`“Mass spectrometry-based discovery of natural product chemoprevention agents”
`Current Position: Senior Scientist, Abbott Laboratories, North Chicago, IL
`15. Angela Calderon, Postdoctoral Fellow, 2006-2008
`“Mass spectrometry-based assays of antioxidants in chocolate”
`Current Position: Assistant Professor of Medicinal Chemistry, Harrison School of Pharmacy,
`Auburn University, Auburn, AL
`16. Yongsoo Choi, Postdoctoral Fellow, 2006-2010
`“Mass spectrometry-based screening for estrogenic natural products”
`Current Position: Scientist at U.S. Food and Drug Administration, Silver Spring, MD
`17. Sigrid Baumgarten, Postdoctoral Fellow, 2009-2011
`“Mass spectrometry-based chemoprevention agent discovery and development”
`18. Shunyan Mo, Postdoctoral Fellow, 2009-present
`“Cyclooxygenase inhibitors in cocoa”
`
`Visiting Scholars
`Florentina Catana, 1998
`State Institute for Drug Control and Pharmaceutical Research, Bucharest, Romania
`Mine Bilsel, 2000
`Tübitak Marmara Materials and Chemical Technologies Research Institute, Tübitak, Turkey
`Genying Xu, 2001
`Shongshan Hospital, Fudan University. Shanghai, Peoples Republic of China
`Sara Madelene Johannson, 2002
`Swedish University of Agricultural Sciences, Uppsala, Sweden.
`Zeying Wei, 2004
`
`
`
`
`
`
`30
`
`
`
`0000062
`
`

`
`April 2012
`
`Associate Professor, Department of Traditional Pharmaceutics, Yunnan University of Traditional
`Chinese Medicine, P.R.China.
`Selin Bolca, 2009
`Laboratory of Phytochemistry and Pharmacognosy, Ghent University
`Gent, Belgium.
`
`Masters of Science Thesis Committee Memberships
`LaShaunda King, 1998. Medicinal Chemistry, University of Illinois College of Pharmacy.
`Yumei Chen, 1999. Pharmacognosy, University of Illinois College of Pharmacy
`DNA damage and induction of apoptosis by the equine estrogen metabolite 4-hydroxyequilenin.
`Dan Yao, 2001. Medicinal Chemistry, University of Illinois College of Pharmacy
`Synthesis and reactivity of potential toxic metabolites of tamoxifen analogues: droloxifene and
`toremifene o-quinones.
`Tracy Katz, 2002. Nutrition, University of Illinois College of Allied Health Sciences
`Nutrient consumption of men with prostate cancer vs. men with high PSA but biopsy negative.
`Hua Wei, 2007. Public Health Sciences, University of Illinois School of Public Health
`Analytical method enhancement of PBDEs in the environmental samples from lake sediment,
`indoor dust and sludge.
`Stephanie M. Schlecht, 2007. Pharmacognosy, University of Illinois College of Pharmacy
`Preliminary biochemical studies on Vitex agnus-castus L.
`
`Dissertation Committee Memberships
`Samuel B. Wainhaus, 1997. Chemistry, University of Illinois at Chicago, College of Liberal Arts
`and Sciences. Experimental studies of polyatomic ion interactions with clean and adsorbate
`covered metal surfaces.
`Li Shen, 1998. Medicinal Chemistry, University of Illinois College of Pharmacy
`Mei-Shiang Jang, 1998. Pharmacognosy, University of Illinois College of Pharmacy
`Hanjo Lim, 1999. Chemistry, University of Illinois at Chicago College of Liberal Arts and
`Sciences. Energetics studies of organic and biomolecular ions by surface-induced dissociation.
`Liqiong Fang, 1999. Pharmacognosy, University of Illinois College of Pharmacy
`Cytotoxic constituents of Dichapetalum gelonioides iand Brachistus stramonifolius.
`Peter Wei-Jen Fan, 2000. Medicinal Chemistry, University of Illinois College of Pharmacy
`Synthesis, reactivity and bioactivation screening of potential carcinogenic metabolites of
`triphenylethylene antiestrogens.
`Hans E. Westenburg, 2000. Pharmacognosy, University of Illinois College of Pharmacy
`Potential cancer chemopreventive agents from Cotinus coggygria and Petiveria alliacea.
`Minsun Chang, 2000. Medicinal Chemistry, University of Illinois College of Pharmacy.
`Structural and functional consequences of catechol estrogen mediated inactivation of glutathione
`S-transferases.
`Fagen Zhang, 2000. Medicinal Chemistry, University of Illinois College of Pharmacy
`
`
`
`
`
`
`31
`
`
`
`0000063
`
`

`
`April 2012
`
`Synthesis and reactivity of potential carcinogenic catechol metabolites from equine estrogens
`and tamoxifen.
`Liming Zhang, 2000. Medicinal Chemistry, University of Illinois College of Pharmacy
`Amit S. Kulkarni, 2000. Medicinal Chemistry, University of Illinois College of Pharmacy
`LaShaunda T. King, 2001. Medicinal Chemistry, University of Illinois College of Pharmacy
`Longwen Chen, 2001. Human Nutrition and Dietectics, University of Illinois College of Allied
`Health Sciences.
`Joel J. Gills, 2001. Pharmacognosy, University of Illinois College of Pharmacy
`Yi Han, 2001. Medicinal Chemistry, University of Illinios College of Pharmacy
`Lixin Shen, 2002. Medicinal Chemistry, University of Illinois College of Pharmacy
`Xuemei Liu, 2003. Medicinal Chemistry, University of Illinois College of Pharmacy
`Genotoxic effects induced by equine estrogen metabolites in breast cancer cells.
`Lucas R. Chadwick, 2004. Pharmacognosy, University of Illinois College of Pharmacy
`Estrogens and congeners from spent hops.
`Chien Ma, 2004. Biopharmaceutical Sciences, University of Illinois College of Pharmacy
`Hyunyoung Jeong, 2004. Biopharmaceutical Sciences, University of Illinois College of
`Pharmacy.
`Yan Li, 2004. Medicinal Chemistry, University of Illinois College of Pharmacy
`Xiaoyan Zhao, 2004. Chemistry, University of Illinois College of Liberal Arts and Sciences
`Methods of determination of dilute peptide and protein content in small volume biological
`samples
`Xiao Zhang, 2005. Pharmacognosy, University of Illinois College of Pharmacy
`Nancy L. Booth, 2005. Pharmacognosy, University of Illinois College of Pharmacy
`Red clover (Trifolium pratense) as a botanical dietary supplement.
`Hsuan-Ming Yao, 2005. Biopharmaceutical Sciences, University of Illinois College of Pharmacy
`Li Zhu, 2005. Biopharmaceutical Sciences, University of Illinois College of Pharmacy
`Zhuohua Wang, 2005. Pharmacognosy, University of Illinios College of Pharmacy
`Ju Liu, 2005. Medicinal Chemistry, University of Illinois College of Pharmacy
`Xiaoliang Yan. Biopharmaceutical Sciences, University of Illinois College of Pharmacy
`Jill D. Dombrauckas, 2006. Medicinal Chemistry, University of Illinois College of Pharmacy
`Structure determination and kinetic characterization of the tumor-specific pyruvate kinase M2.
`Daniel S. Fabricant, 2006. Pharmacognosy, University of Illinois College of Pharmacy
`Pharmacognostic investigation of black cohosh (Cimicifuga racemosa (L.) Nutt.)
`Hong Liu, 2006. Medicinal Chemistry, University of Illinois College of Pharmacy
`Bioactivation of SERMS desmethylated arzoxifene and raloxifene to quinoids.
`Allison Turner, 2006. Pharmacognosy, University of Illinois College of Pharmacy
`
`
`
`
`
`
`32
`
`
`
`0000064
`
`

`
`April 2012
`
`The pharmacognosy of cranberries (Vaccinium macrocarpon Aiton) as a urologic dietary
`supplement.
`Barbara Calamini, 2007. Medicinal Chemistry, University of Illinois College of Pharmacy
`Towards the molecular bases for the health benefits of resveratrol and its metabolites.
`Cassia Rose Overk, 2007. Pharmacognosy, University of Illinois College of Pharmacy
`Estrogenic evaluation of botanicals as possible alternatives to hormone replacement therapy.
`Huu Thi Nguyen, 2008. Pharmacognosy, University of Illinois College of Pharmacy
`Palatable prophylaxis based on traditional Vietnamese health beliefs: an appealing approach to
`medicine.
`Jialin Mao, 2008. Medicinal Chemistry, University of Illinois College of Pharmacy
`From serendipity to rational antituberculosis drug discovery on mefloquine-based ligands.
`Zhican Wang, 2009. Medicinal Chemistry, University of Illinois College of Pharmacy
`Activation and genotoxic consequences of the Premarin equine estrogen metabolites to reactive
`quinones.
`Chuan Bai, 2010. Medicinal Chemistry, University of Illinois College of Pharmacy
`Bacterial calcium-dependent phosphatidylinositol-specific phospholipase C: Mechanism and
`applications.
`Megan Sturdy, 2010. Medicinal Chemistry, University of Illinois College of Pharmacy
`Natural product drug discovery regarding Mycobacterium tuberculosis and quinine reductase-2.
`Boobalan Pachaiyappan, 2011. Medicinal Chemistry, University of Illinois College of Pharmacy
`Structure- and ligand-based modeling of β-secretase 1 (BACE1) inhibitors.
`Jay Kalin, 2012. Medicinal Chemistry, University of Illinois College of Pharmacy
`Elucidation of the histone deacetylase 6 pharmacophore.
`Su-Young Choi, 2012. Pharmacognosy, University of Illinois College of Pharmacy
`Female Hormone-Mediated Hepatic CYP Regulation: Implications in Altered Drug Metabolism
`during Pregnancy.
`
`PROFESSIONAL ACTIVITIES
`Co-chairman of the Triangle Area Mass Spectrometry Discussion Group, Research Triangle
`Park, NC. 1988-1990
`Chairman of the Desorption Ionization Interest Group for the American Society for Mass
`Spectrometry. 1992-1993
`Member of the Biotechnology Faculty at North Carolina State University. 1986-1993
`Member of the Functional Foods for Health Research Program of the University of Illinois.
`1994-2004
`Member of the Program for Collaborative Research in the Pharmaceutical Sciences, University
`of Illinois at Chicago. 1995-present
`Member of the Board for the Madison-Chicago-Milwaukee (MCM) Mass Spectrometry
`Discussion Group. 1997-2003
`Member of the University of Illinois at Chicago General Clinical Research Center. 1997-2009
`
`
`
`
`
`
`33
`
`
`
`0000065
`
`

`
`April 2012
`
`Member of the University of Illinois at Chicago Cancer Center. 2001-present
`Member of the University of Illinois Center for Clinical and Translational Science. 2009-present
`American Society for Mass Spectrometry Annual Conference Program Committee. 1998, 2011
`Core Advisory Group of the AOAC Official Methods Program for Dietary Supplements. 2003-
`present
`Madison-Chicago-Milwaukee Mass Spectrometry Discussion Group. Member-at-Large 2000-
`2003
`Chicago Mass Spectrometry Discussion Group, Vice President 2004-2009
`AOAC International Dietary Supplements Task Group. Member of Vitamin B6 Expert Review
`Panel 2009
`AOAC International Dietary Supplements Task Group. Chair of Vitamin B12 Expert Review
`Panel 2009
`AOAC Presidential Task Force on Dietary Supplements. 2007-present
`AOAC International Harvey W. Wiley Award Committee. 2010-present
`
`Editorial Board Membership
`Editor-in-Chief, Combinatorial Chemistry & High Throughput Screening, published by Bentham
`Science Publishers. 1997-2010.
`Editor-in-Chief emeritus, Combinatorial Chemistry & High Throughput Screening, published by
`Bentham Science Publishers. 2010-present.
`Editorial Board, Assay and Drug Development Technologies, published by Mary Ann Liebert,
`Inc. Publishers. 2010-present.
`Editorial Board, BenSci Science Newsletter, published by Bentham Science Publishers. 2009-
`present.
`Editorial Board, Biomedical Chromatography, published by Wiley Interscience. 2006-present.
`
`Membership in Professional Societies
`American Chemical Society
`AOAC International
`American Society for Mass Spectrometry
`International Carotenoid Society
`International Society for the Study of Xenobiotics
`Sigma Xi
`
`Federal Government Public Advisory Committee Service
`National Cancer Institute, Initial Review Group, Site Visit Review Committee NCI-A RTRB-L
`(E1). Ann Arbor, MI. October 4-6, 2011.
`
`
`
`
`
`
`34
`
`
`
`0000066
`
`

`
`April 2012
`
`National Cancer Institute, Initial Review Group, Site Visit Review Committee NCI-A RTRB-H
`(22). University of Colorado Cancer Center, 2 P30 CA046934-24. Aurora, CO. June 14-16,
`2011.
`National Institutes of Health, Center for Scientific Review, ZRG1 OTC-H (14) Oncology 2 –
`Translational Clinical IRG. March 15-16, 2011.
`National Institutes of Health, Center for Scientific Review Special Emphasis Panel, ZRG1 OTC-
`B (02) M Cancer Prevention. September 3, 2010.
`National Institutes of Health, Center for Scientific Review, Oncology 2 – Translational Clinical
`Integrated Review Group. Cancer Biomarkers Study Section (CBSS), Alexandria, VA. June 7-8,
`2010.
`National Cancer Institute, Site Visit Review Committee, University of Pittsburgh Cancer
`Institute, ZCA1 RTRB-L (E3) 2 P30 CA047904-22. Pittsburgh, PA. February 16-18, 2010.
`National Institutes of Health, Center for Scientific Review, Oncology 2 – Translational Clinical
`Integrated Review Group. Cancer Biomarkers Study Section (CBSS), Alexandria, VA. February
`1-2, 2010.
`National Institutes of Health, Center for Scientific Review, ZRG1 OTC-B 02 M, Cancer
`Prevention. September 22, 2009.
`National Institutes of Health, Center for Scientific Review, ZRG1 OTC-B 97 M, Cancer Therapy
`ARRA-CA. July 16, 2009.
`National Institutes of Health, Center for Scientific Review, ZRG1 BCMB-P (58) R; Road Map:
`Challenge Grants Panel 5. July 20-21, 2009.
`National Institutes of Health, Center for Scientific Review, ZRG1 BST-J (52) R; Road Map:
`Development of Assays for High Throughput Screening. Chairman of Review Panel, July 2008.
`National Institutes of Health, Center for Scientific Review, ZRG1 BCMB-H 50 R; Road Map
`RM08-004: New Methodologies for Natural Products Chemistry. Review panel member 2008.
`National Institutes of Health, Center for Scientific Review Special Emphasis Panel, ZRG1 F09-B
`20 L Oncology Fellowship. Review panel member February 28-29, 2008.
`National Institutes of Health, Center for Scientific Review, ZRG1 BCMB-M 10 B, Chemistry
`Biophysics Special Emphasis Panel (successor to ZRG3 SSS-6). Review panel member 2006-
`present.
`NIH National Center for Research Resources Special Emphasis Panel ZRR1 BT-B, Biomedical
`Technology. Review panel member 2005-present.
`NIH Center for Scientific Review, ZRG1 ONC-B 03, Dietary Factors and Cancer. Review panel
`member 2007.
`National Institutes of Health, Center for Scientific Review, Biophysical and Chemical Sciences
`Review Group, ZRG1 SSS-6 and ZRG3 SSS-6 (reviewing analytical methods and instrument-
`based grant proposals). Review panel member 1996-2005.
`National Cancer Institute, Rapid Access to Intervention Development (RAID) Program. Review
`panel member 2005.
`NIH National Center for Research Resources Special Emphasis Panel ZRG1 Onc-L (03)M
`Cancer Biomarkers. Review panel member June, 2005.
`
`
`
`
`
`
`35
`
`
`
`0000067
`
`

`
`April 2012
`
`National Center for Research Resources, Special Emphasis Panel ZRR1 BT-6 01. Review panel
`member, October, 2005.
`National Institutes of Health, Center for Scientific Review Special Emphasis Panel, ZRG SSS-6
`(12). Chairperson of Chemistry/Biophysics SBIR/STTR Panel. August 11, 2004.
`National Institutes of Health, Center for Scientific Review Special Emphasis Panel, ZRG1 TME
`(04). Cancer Drug Discovery and Delivery. Review panel member, January 2004.
`National Center for Complementary and Alternative Medicine. ZAT1 CP (12) Review panel
`member, October, 2003.
`National Cancer Institute, Special Emphasis Panel. ZCA1 SRRB-K J2 S, Small Grants Program
`for Cancer Epidemiology and Cancer Prevention Research. December 3-4, 2002.
`National Center on Complementary and Alternative Medicine ad hoc Working Group on
`Research on PC-SPES for prostate cancer: Developing a Strategy. Bethesda, MD. August 12,
`2002.
`National Cancer Institute, Special Emphasis Panel. RFA 01-020 Shared Resources for Scientists
`not at NCI Funded Centers. November, 2001.
`National Cancer Institute, Special Emphasis Panel. SBIR Topic 178 Chemical Diversity-Based
`Methods Identifying New Tumor Markers or Probes. Chairperson. March 13, 2000.
`National Cancer Institute, Subcommittee C – Basic & Preclinical Program grants. Review panel
`member, September 19, 2000.
`National Cancer Institut